111 related articles for article (PubMed ID: 5426952)
1. A clinical evaluation of a prolonged schedule of cytosine arabinoside (NSC63878).
Burke PJ; Owens AH; Colsky J; Shnider BI; Edmonson JH; Schilling A; Brodovsky HS; Wallace HJ; Hall TC
Cancer Res; 1970 May; 30(5):1512-5. PubMed ID: 5426952
[No Abstract] [Full Text] [Related]
2. Mitomycin (Mutamycin).
Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
[No Abstract] [Full Text] [Related]
3. A clinical evaluation of dose and schedule of administration of cytosine arabinoside (NSC 63878).
Burke PJ; Serpick AA; Carbone PP; Tarr N
Cancer Res; 1968 Feb; 28(2):274-9. PubMed ID: 4868015
[No Abstract] [Full Text] [Related]
4. Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma.
Hart JS; Ho DH; George SL; Salem P; Gottlieb JA; Frei E
Cancer Res; 1972 Dec; 32(12):2711-6. PubMed ID: 4644204
[No Abstract] [Full Text] [Related]
5. [Continuous venous infusion in cancer chemotherapy].
Ota K
Gan To Kagaku Ryoho; 1985 Apr; 12(4):798-805. PubMed ID: 2580486
[TBL] [Abstract][Full Text] [Related]
6. Re-evaluation of methotrexate as an anticancer drug.
Sullivan RD; Miller E; Zurek WZ; Oberfield RA; Ojima Y
Surg Gynecol Obstet; 1967 Oct; 125(4):819-24. PubMed ID: 6041727
[No Abstract] [Full Text] [Related]
7. Clinical evaluation of 5-bromo-5-fluoro-6-methoxy-dihydro-2'-deoxyuridine.
Van Dyk JJ; Clarkson BD; Duschinsky R; Keller O; La Sala E; Krakoff IH
Cancer Res; 1967 Nov; 27(11):2129-36. PubMed ID: 4294532
[No Abstract] [Full Text] [Related]
8. Preliminary clinical trial and the physiologic disposition of 4(5)-(3,3-dimethyl-1-triazeno)imidazole-5(4)-carboxamide in man.
Skibba JL; Ramirez G; Beal DD; Bryan GT
Cancer Res; 1969 Nov; 29(11):1944-51. PubMed ID: 5358212
[No Abstract] [Full Text] [Related]
9. [Experience with the treatment of patients with malignant tumors with 5-fluorouracil].
Milonov BV; Kosarev VA; Nikiforov AM
Vopr Onkol; 1967; 13(12):55-61. PubMed ID: 5597532
[No Abstract] [Full Text] [Related]
10. Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors.
Davis HL; Rochlin DB; Weiss AJ; Wilson WL; Andrews NC; Madden R; Sedransk N
Oncology; 1974; 29(3):190-200. PubMed ID: 4412696
[No Abstract] [Full Text] [Related]
11. Anticancer therapy with hydrea: comparative study of daily vs. intermittent oral dosage.
Ariel IM
J Surg Oncol; 1974; 6(1):73-8. PubMed ID: 4819359
[No Abstract] [Full Text] [Related]
12. Cancer chemotherapy. I. Methods, agents and overall results in 400 patients.
Hill GJ; Larsen RR
Oncology; 1972; 26(2):206-22. PubMed ID: 4626137
[No Abstract] [Full Text] [Related]
13. Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature.
Nathanson L; Hall TC; Schilling A; Miller S
Cancer Res; 1969 Feb; 29(2):419-25. PubMed ID: 4885390
[No Abstract] [Full Text] [Related]
14. Phase II study of cyclophosphamide and cytarabine in the treatment of metastatic adenocarcinoma of the colon and rectum.
Denefrio JM; Kaplan RS; Eisenberger MA; Lessner HE
Cancer Treat Rep; 1981; 65(1-2):163-4. PubMed ID: 7226166
[No Abstract] [Full Text] [Related]
15. New approaches in administration of anticancer drugs.
Rall DP
Cancer Res; 1969 Dec; 29(12):2471-4. PubMed ID: 5369694
[No Abstract] [Full Text] [Related]
16. Postsurgical adjuvant chemotherapy: a review.
Diekamp U; Lad TE; McGuire WP
Surg Annu; 1981; 13():31-52. PubMed ID: 7025285
[No Abstract] [Full Text] [Related]
17. Cytosine arabinoside (NSC-63878)--clinical brochure.
Livingston RB; Carter SK
Cancer Chemother Rep 3; 1968 Dec; 1(1):179-205. PubMed ID: 4989814
[No Abstract] [Full Text] [Related]
18. Combination chemotherapy using cyclophosphamide, vincristine, methotrexate and 5-fluorouracil in solid tumors.
Costanzi JJ; Coltman CA
Cancer; 1969 Mar; 23(3):589-96. PubMed ID: 4304025
[No Abstract] [Full Text] [Related]
19. Dose schedule and antitumor studies of arabinosyl cytosine (NSC 63878).
Frei E; Bickers JN; Hewlett JS; Lane M; Leary WV; Talley RW
Cancer Res; 1969 Jul; 29(7):1325-32. PubMed ID: 5799155
[No Abstract] [Full Text] [Related]
20. Effect of cytosine arabinoside and 1,3-bis(2-chloroethyl)-1-nitrosourea on hematopoietic precursors in the mouse.
Preisler HD; Henderson ES
J Natl Cancer Inst; 1971 Nov; 47(5):971-7. PubMed ID: 5123339
[No Abstract] [Full Text] [Related]
[Next] [New Search]
